Sanofi SA Company Profile (EPA:SAN)

About Sanofi SA

Sanofi SA logoSanofi SA, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. It operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation. Its pharmaceuticals portfolio consists of products and a range of prescription medicines, generic medicines and consumer health products. The Vaccines segment is dedicated to vaccines, including research, development, production and marketing. The Animal Health segment includes the research, development, production and marketing activities of Merial, which offers a range of medicines and vaccines for a range of animal species. It operates in the Other segment, which includes the effects of retained commitments. It operates through Regeneron Pharmaceuticals Inc.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: EPA
  • Symbol: SAN
  • CUSIP:
Key Metrics:
  • Previous Close: $80.55
  • 50 Day Moving Average: $25.48
  • 200 Day Moving Average: $25.74
  • Trailing P/E Ratio: 22.01
  • P/E Growth: 2.77
  • Market Cap: $103.34B
Additional Links:

Analyst Ratings

Consensus Ratings for Sanofi SA (EPA:SAN) (?)
Ratings Breakdown: 1 Sell Rating, 9 Hold Ratings, 6 Buy Ratings
Consensus Rating:Hold (Score: 2.31)
Consensus Price Target: €83.73

Analysts' Ratings History for Sanofi SA (EPA:SAN)
Show:
DateFirmActionRatingPrice TargetDetails
2/17/2017Jefferies Group LLCSet Price TargetNeutral€85.00View Rating Details
2/15/2017Kepler Capital MarketsSet Price TargetBuy€89.00View Rating Details
2/9/2017Deutsche Bank AGSet Price TargetBuy€96.00View Rating Details
2/9/2017Goldman Sachs Group, Inc. (The)Set Price TargetNeutral€81.00View Rating Details
2/8/2017Morgan StanleySet Price TargetBuy€91.00View Rating Details
2/6/2017J P Morgan Chase & CoReiterated RatingSellView Rating Details
1/6/2017Citigroup Inc.Reiterated RatingNeutralView Rating Details
1/6/2017Sanford C. BernsteinSet Price TargetNeutral€77.00View Rating Details
12/6/2016S&P Global Inc.Set Price TargetNeutral€80.00View Rating Details
11/1/2016Berenberg BankSet Price TargetBuy€92.00View Rating Details
10/31/2016Societe GeneraleSet Price TargetBuy€96.00View Rating Details
9/14/2016BNP ParibasSet Price TargetNeutral€78.00View Rating Details
6/30/2016Independent Research GmbHSet Price TargetNeutral€77.00View Rating Details
6/9/2016Baader BankSet Price TargetNeutral€78.00View Rating Details
5/12/2016Barclays PLCSet Price TargetBuy€84.00View Rating Details
5/3/2016HSBC Holdings plcSet Price TargetNeutral€81.00View Rating Details
2/9/2016S&P Equity ResearchSet Price TargetBuy€85.00View Rating Details
10/30/2015Credit Suisse GroupSet Price TargetBuy€100.00View Rating Details
(Data available from 2/20/2015 forward)

Earnings

Earnings History for Sanofi SA (EPA:SAN)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Sanofi SA (EPA:SAN)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Sanofi SA (EPA:SAN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sanofi SA (EPA:SAN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Sanofi SA (EPA:SAN)
DateHeadline
finance.yahoo.com logoSanofi : Disclosure of trading in own shares (EPA:SAN)
finance.yahoo.com - February 20 at 6:53 PM
wsj.com logoAppeals Court Allows Sanofi, Regeneron to Continue Selling Cholesterol Drug (EPA:SAN)
www.wsj.com - February 15 at 1:49 AM
finance.yahoo.com logoSanofi :Disclosure of trading in own shares (EPA:SAN)
finance.yahoo.com - February 14 at 6:09 AM
bloomberg.com logoSanofi Nears Agreement to Sell Some Over-the-Counter Drugs to Ipsen: Source (EPA:SAN)
www.bloomberg.com - February 13 at 12:35 AM
News IconSanofi nears deal to sell some over-the-counter drugs to Ipsen (EPA:SAN)
health.economictimes.indiatimes.com - February 13 at 12:35 AM
wsj.com logoSanofi Seeks Cure for FDA Concerns at French Factory (EPA:SAN)
www.wsj.com - February 13 at 12:35 AM
4-traders.com logoBRIEF-Sanofi nearing deal to sell some over-the-counter products to Ipsen for about 100 mln euros- Bloomberg, citing source … (EPA:SAN)
www.4-traders.com - February 13 at 12:35 AM
reuters.com logoSanofi nears deal to sell some over-the-counter drugs to Ipsen: Bloomberg (EPA:SAN)
www.reuters.com - February 13 at 12:35 AM
4-traders.com logoSanofi $SNY Expected to Post Q1 2017 Earnings of $0.75 Per Share (EPA:SAN)
www.4-traders.com - February 12 at 8:12 AM
4-traders.com logoThe implications of the Sanofi patent injunction stay: https://t.co/HwcJ4ULP8U by @jsherkow (EPA:SAN)
www.4-traders.com - February 10 at 11:39 PM
News IconUSA appeals court allows Regeneron, Sanofi to continue selling cholesterol drug (EPA:SAN)
eleganthomesinla.com - February 10 at 11:39 PM
News IconSanofi and Regeneron secure stay of Praluent injunction (EPA:SAN)
mlbinjurynews.com - February 10 at 11:39 PM
investing.com logoFrance stocks higher at close of trade; CAC 40 up 1.25% (EPA:SAN)
www.investing.com - February 10 at 1:53 AM
News IconRegeneron, Sanofi win stay of order blocking cholesterol drug sales (EPA:SAN)
www.channelnewsasia.com - February 10 at 1:53 AM
News IconFrance stocks higher at clоse оf trade; CAC 40 up 1.25% (EPA:SAN)
newscame.com - February 10 at 1:53 AM
4-traders.com logoSanofi SA given €96.00 PT by Deutsche Bank AG. buy rating. (EPA:SAN)
www.4-traders.com - February 10 at 1:53 AM
News IconADRs End Higher; Sanofi Rise (EPA:SAN)
ih.advfn.com - February 10 at 1:53 AM
News IconSanofi SA (ADR) (NYSE:SNY) Heffx Trading Outlook - Live Trading News (EPA:SAN)
www.livetradingnews.com - February 9 at 5:23 AM
4-traders.com logoSanofi SA given €91.00 PT by Morgan Stanley. buy rating. (EPA:SAN)
www.4-traders.com - February 9 at 12:22 AM
marketwatch.com logoSanofi: Plant problem that concerned FDA is fixed (EPA:SAN)
www.marketwatch.com - February 9 at 12:22 AM
rttnews.com logoSanofi Stock Up As Q4 Profit More Than Doubles (EPA:SAN)
www.rttnews.com - February 8 at 5:01 AM
marketwatch.com logoSanofi 4Q net profit more than doubles - MarketWatch (EPA:SAN)
www.marketwatch.com - February 8 at 5:01 AM
bloomberg.com logoSanofi CFO: Offering New Treatments for Diabetes (EPA:SAN)
www.bloomberg.com - February 8 at 5:01 AM
marketwatch.com logoEuropean stocks rise, but Maersk sinks after cutting dividend (EPA:SAN)
www.marketwatch.com - February 8 at 5:01 AM
newsmaker.com.au logoGlobal Vascular Endothelial Growth Factor Market 2017 : Sanofi SA, Warner Chilcott plc, GlaxoSmithKline Plc, Eli Lilly and Company (EPA:SAN)
www.newsmaker.com.au - February 7 at 8:12 AM
4-traders.com logo01/31 Sanofi SA's sell rating reiterated at J P Morgan Chase & Co. (EPA:SAN)
www.4-traders.com - February 6 at 7:47 PM
News IconReady to inject your child with “safe” vaccines from China? (EPA:SAN)
jonrappoport.wordpress.com - February 5 at 8:12 AM
4-traders.com logoSanofi SA given €87.00 PT by Kepler Capital Markets. buy rating. (EPA:SAN)
www.4-traders.com - February 3 at 11:50 PM
investopedia.com logoAmgen’s Repatha Sales Surpass Praluent (AMGN, REGN) (EPA:SAN)
www.investopedia.com - February 2 at 12:35 AM
finance.yahoo.com logoSanofi's Xyzal® Allergy 24HR Approved for Over-the-Counter Use in the United States (EPA:SAN)
finance.yahoo.com - February 1 at 3:21 AM
finance.yahoo.com logoSanofi Appoints Hugo Fry as General Manager UK (EPA:SAN)
finance.yahoo.com - February 1 at 3:21 AM
openpr.com logoGlobal Type 1 Diabetes Market to grow at a CAGR of 8.05% during 2016-2020: Key Vendors are Sanofi SA, Novo Nordisk A/S, Eli Lilly and Company (EPA:SAN)
www.openpr.com - January 31 at 10:19 PM
News IconNovo Nordisk sued by group of US patients (EPA:SAN)
cphpost.dk - January 31 at 10:19 PM
News IconEli Lilly and Co (NYSE:LLY) & Sanofi SA (ADR)(NYSE:SNY) Among Others Accused Of Price Fixing On Insulin (EPA:SAN)
randolphguide.com - January 31 at 10:19 PM
News IconSanofi SA (SNY), Novo Nordisk (NVO) And Eli Lilly (LLY) Stock…Being Sent To The Corn Field (EPA:SAN)
cnafinance.com - January 31 at 10:19 PM
finance.yahoo.com logoSanofi Pasteur Announces the Availability of Quadracel™ DTaP-IPV Vaccine for Children 4 Through 6 Years of Age in the U.S. (EPA:SAN)
finance.yahoo.com - January 31 at 10:19 PM
finance.yahoo.com logoLilly revenue beats as diabetes drug sales rise (EPA:SAN)
finance.yahoo.com - January 31 at 10:19 PM
reuters.com logoSanofi, Novo Nordisk and Lilly named in patients' price fixing suit - Reuters (EPA:SAN)
www.reuters.com - January 31 at 2:18 AM
News IconLawsuit accuses drug makers of scheming to fix insulin prices (EPA:SAN)
www.bostonglobe.com - January 30 at 9:02 PM
reuters.com logoBRIEF-Gener8 Maritime estimates interest expense to be about $18.3 mln for three months ended Dec. 31 (EPA:SAN)
www.reuters.com - January 30 at 9:02 PM
finance.yahoo.com logoSanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs (EPA:SAN)
finance.yahoo.com - January 30 at 1:10 AM
reuters.com logoAmgen opposes doctors weighing in on cholesterol drug patent fight (EPA:SAN)
www.reuters.com - January 28 at 6:18 AM
News IconSanofi (SNY) Stock Declined While Hamlin Capital Management ... - The Randolph Guide (EPA:SAN)
randolphguide.com - January 28 at 6:18 AM
finance.yahoo.com logoSanofi left looking after J&J swipes Actelion in $30B deal - Yahoo Finance (EPA:SAN)
finance.yahoo.com - January 27 at 2:43 AM
4-traders.com logoJohnson & Johnson : to Acquire Actelion in $30 Billion Deal -- Update (EPA:SAN)
www.4-traders.com - January 26 at 4:40 AM
News IconCasebia starts to build 'sustainable organization' (EPA:SAN)
www.bioworld.com - January 26 at 4:40 AM
investopedia.com logoFlat Prospects for Sanofi in the Near Future? (SNY) - Investopedia (EPA:SAN)
www.investopedia.com - January 23 at 8:00 PM
live-pr.com logoSanofi SA - Strategy, SWOT and Corporate Finance Report - New Study Released (EPA:SAN)
www.live-pr.com - January 23 at 8:51 AM
finance.yahoo.com logoSanofi: Availability of the Pre-quarterly Results Communication (EPA:SAN)
finance.yahoo.com - January 23 at 8:51 AM
biz.yahoo.com logoPreliminary Q4 2016 Sanofi SA Earnings Release - 01:30 am ET (EPA:SAN)
biz.yahoo.com - January 23 at 8:51 AM

Social

What is Sanofi SA's stock symbol?

Sanofi SA trades on the EPA under the ticker symbol "SAN."

Where is Sanofi SA's stock going? Where will Sanofi SA's stock price be in 2017?

16 analysts have issued 12 month target prices for Sanofi SA's stock. Their forecasts range from €71.00 to €96.00. On average, they expect Sanofi SA's stock price to reach €83.73 in the next twelve months.


Last Updated on 2/20/2017 by MarketBeat.com Staff